Hans‐Michael Steffen

4.6k citations
139 papers · 3.2k indexed · 1 hit paper · h-index 29
Topics
Liver Disease Diagnosis and Treatment (34 papers)Liver Disease and Transplantation (14 papers)Diet, Metabolism, and Disease (9 papers)

In The Last Decade

Hans‐Michael Steffen

134 papers receiving 3.1k citations

Hit Papers

NAFLD and cardiovascular diseases: a clinical review20202026202220242020100200300

Peers

Hans‐Michael Steffen
Comparison fields: 5 of 139
  • Epidemiology 1.1k
  • Molecular Biology 869
  • Endocrinology, Diabetes and Metabolism 521
  • Hepatology 447
  • Physiology 437
Replace Bruce F. Scharschmidt with:
Bruce F. Scharschmidt United States
Kazuya Higashino Japan
Hisahiko Sekihara Japan
Akiko Eguchi Japan
Graham Robertson Australia
Thomas Geiger Germany
Cheng Ji United States
Peter Brouckaert Belgium
Bernard M. Jaffe United States
Takao Yamada Japan
Hans‐Michael Steffen relative to Bruce F. Scharschmidt United States Bruce F. Scharschmidt's profile →
Citations per field
00.5×4.7×
Bruce F. Scharschmidt · 1×
Citations per year

Countries citing papers authored by Hans‐Michael Steffen

Since Specialization
Citations

This map shows the geographic impact of Hans‐Michael Steffen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans‐Michael Steffen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans‐Michael Steffen more than expected).

Fields of papers citing papers by Hans‐Michael Steffen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans‐Michael Steffen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans‐Michael Steffen. The network helps show where Hans‐Michael Steffen may publish in the future.

Co-authorship network of co-authors of Hans‐Michael Steffen

This figure shows the co-authorship network connecting the top 25 collaborators of Hans‐Michael Steffen. A scholar is included among the top collaborators of Hans‐Michael Steffen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans‐Michael Steffen. Hans‐Michael Steffen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 19
3 5
4 2
5 8
6 131
7 22
8 15
9 7
10 2
11 3
12 45
13 29
14 3
15 1
16
Amlodipine - a third generation dihydropyridine calcium antagonist
11
17 12
18 109
19
Microscopic findings after tissue sticking with autologous fibrin
1
20
[Appendicitis in childhood--an analytical study].
1

About Hans‐Michael Steffen

Hans‐Michael Steffen is a scholar working on Hepatology, Microbiology and Gastroenterology, having authored 139 papers that have together received 3.2k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (34 papers), Liver Disease and Transplantation (14 papers) and Diet, Metabolism, and Disease (9 papers). The work is most often cited by research in Hepatology (447 citations), Epidemiology (1.1k citations) and Endocrinology, Diabetes and Metabolism (521 citations). Hans‐Michael Steffen has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Münevver Demir, Sonja Lang, W. Hein, A. Supersaxo, Tobias Goeser, Philipp Kasper, Anna Martin, Fabian Kütting, H. Van der Loos and Jochem Alsenz. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026